Eli Lilly and Co. LLY on Monday shared positive topline results from the Phase 3 LIBRETTO-432 clinical trial for Retevmo ...

Our scalable NLP system enabled us to generate real-world insights into NSCLC recurrences, paving the way for predictive models for preventing, diagnosing, and treating NSCLC recurrence. Our NLP ...

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at London’s Francis Crick Institute and University College London, ...

Samsung Medical Center announced that its researchers have developed a new AI model capable of predicting the recurrence risk of non-small cell lung cancer up to a year in advance. According to the ...

Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...

Lung cancer recurrence is when cancer comes back after at least a year of being undetectable. Lung cancer often recurs within five years and is usually metastatic, meaning it has spread. Treatments ...

Molecular residual disease (MRD) testing detects cancer recurrence months before traditional imaging Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA ...

Doctors at the University of Cincinnati Cancer Center are exploring whether personalized mRNA vaccines are effective at reducing lung cancer recurrence.The vaccines are developed from a patient's own ...

An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for the treatment of recurrent lung cancer, according to new research ...

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...